REFERENCES
- LewyAJ.KernHA.RosenthalNE.WehrTA.Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle.Am J Psychiatry.1982139149614987137404
- RosenthalNE.SackDA.GillinJC.et al.Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy.Arch Gen Psychiatry19844172806581756
- LewyAJ.SackRL.SingerCM.Assessment and treatment of chronobiologic disorders using plasma melatonin levels and bright light exposure: the clockgate model and the phase response curve.Psychopharmacol Bull.1984205615656473662
- RosenthalNE.SkwererRG.JacobsonFM.HardinTA.WehrTA.Phototherapy: the NIMH experience. In: Thompson C, SilverstoneT, eds.Seasonal Affective Disorder. London, UK: CRC Clinical Neuroscience;1988
- WehrTA.JacobsenFM.SackDA.ArendtJ.TamarkinL.RosenthalNE.Phototherapy of seasonal affective disorder: time of day and suppression of melatonin are not critical for antidepressant effects.Arch Gen Psychiatry.1986438708753753164
- LewyAJ.SackRL.SingerCM.Treating phase typed chronobiologic sleep and mood disorders using appropriately timed bright artificial light.Psychopharmacol Bull.1985213683724034852
- LewyAJ.SackRL.SingerCM.WhiteDM.The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence.Psychopharmacol Bull.1987233493533324148
- LewyAJ.SackRL.MillerS.HobanTM.Antidepressant and circadian phase-shifting effects of light.Science.19872353523543798117
- LewyAJ.Treating chronobiologic sleep and mood disorders with bright light.Psychiatric Annals.198717664669
- LewyAJ.SackRL.The role of melatonin and light in the human circadian system. In: Buijs R, Kalsbeek A, Romijn H, Pennartz C, Mirmiran M, eds.Progress in Brain Research. Vol, 111, Hypothalamic Integration of Circadian Rhythms. Amsterdam: Elsevier;1996205216
- KlermanEB.GershengornHB.DuffyJF.KronauerRE.Comparisons of the variability of three markers of the human circadian pacemaker.J Biol Rhythms.20021718119312002165
- LewyAJ.SackRL.The dim light melatonin onset (DLMO) as a marker for circadian phase position.Chronobiol Int.19896931022706705
- LewyAJ.CutlerNL.SackRL.The endogenous melatonin profile as a marker for circadian phase position.J Biol Rhythms.19991422723610452335
- lllnerováH.VanecekJ.Two-oscillator structure of the pacemaker controlling the circadian rhythm of N-acetyltransferase in the rat pineal gland.J Comp Physiol [A].1982145539548
- ParryBL.BergaSL.KripkeDF.et al.Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression.Arch Gen Psychiatry.199047113911462244799
- WehrTA.The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod).J Clin Endocrinol Metabol19917312761280
- WehrTA.SchwartzPJ.TurnerEH.Feldman-NaimS.DrakeCL.RosenthalNE.Bimodal patterns of human melatonin secretion consistent with a two-oscillator model of regulation.Neurosci Lett.19951941051087478188
- LewyAJ.AhmedS.JacksonJML.SackRL.Melatonin shifts circadian rhythms according to a phase-response curve.Chronobiol Int.199293803921394610
- LewyAJ.BauerVK.AhmedS.et al.The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to lightChronobiol Int.19981571839493716
- LewyAJ.LeflerBJ.EmensJS.BauerVK.The circadian basis of winter depression.Proc Natl Acad Sci U S A.20061037414741916648247
- TermanJS.TermanM.LoE-S.CooperTB.Circadian time of morning light administration and therapeutic response in winter depression.Arch Gen Psychiatry.200158697511146760
- LewyA.Current understanding and future implications of the circadian uses of melatonin, a neurohormone discovered by Aaron B. Lerner.J Invest Dermatol.20071272082208517700613
- LewyA.WoodsK.KinzieJ.EmensJ.SongerJ.YuhasK.DLMO/M id-sleep interval of six hours phase types SAD patients and parabolically correlates with symptom severity.Sleep.200730(Abstract supplement)A63A64
- LewyAJ.BauerVK.CutlerNL.et al.Morning vs evening light treatment of patients with winter depression.Arch Gen Psychiatry.1998558908959783559
- Wirz-JusticeA.Biological rhythm disturbances in mood disorders.Intl Clin Psychopharmacol.200621S11S15
- KennedySH.EmsleyR.Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.Eur Neuropsychopharmacol.2006169310016249073
- MillanMJ.BroccoM.GobertA.DekeyneA.Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.Psychopharmacology.2005177112